EUROMEDICA  Hanover 1-2  Juni 2007	Advanced methods of diagnosis, treatment and prophylactics
	European Academy of Natural Sciences, Hanover European Scientific Society, Hanover Russian Academy of Natural Sciences, Moscow

Home

Abstracts

Contact

Disclaimer

Introduction: Fibrous-cystic disease (FCD) - is the most widespread disease of the mammary gland, which inflicts 20-60% of women, more often in the age of 30-50 years. According to the statements of Health Care Organization (FCD) - this is dyshormonal, hyper-plastic process in the mammary gland with wide spectrum of profilirative and regressive changes with wrong ratio of epithelic and connective tissue components. There are two main manifestations of the disease; diffusive and knot ones. The treatment of knot form, as a rule, is surgical, whereas to the diffusive form a complex of conservative medicinal activities is normally applied. Diffusive forms of fibrous-cystic disease - is the initial stage of the disease, displaying painful sensations in the mammary gland, which are intensified several days before menstruations. FCD may be provoked by diseases of other parts of the body, misrelated with reproduction system (liver, thyroid gland, pancreatic, adrenal gland). Thus, the treatment should be directed to normalization of the functions of genital organs, nervous system, liver, thyroid and pancreatic glands, adrenal gland. Therefore we have elaborated the complex on the basis of BAA rendering a considerable and multisided medicinal effect and affecting the causes of fibrous-cystic disease.

Objective: To evaluate the efficiency of the use of two treatment schemes of fibrous-cystic disease on the basis of homeopathic remedy with dopaminergic effect “Mastodinon”. In the first scheme in combination with preparations “Clanjin” and “Asvit” and in the second with the complex of BAA offered by us.

Materials and Methods: The results of treatment were analyzed on 24 cases of FCD in diffusive forms. The patients were divided in two groups, 12 people in each. In the first group (control) the treatment was implemented with mastodinon preparations, aevit and clamin. In the second group the patients were treated with mastodinon in conjunction with the complex on the basis of BAA. The following preparations were involved: Melbrozia, Rodaxon, Selentin, Trioson, Laminaria. With account of the accompanying pathology and with consideration of evidences of the treatment the following preparations were added: gasterol, cistophit and rastaropsha. The treatment lasted 3 months in both groups.

Results: The most frequent complaints of the patients were associated with the pain in mammary glands before menstruations. In most of the patients majority of was managed to the pain syndrome was stopped or was shifted to the background or decreased its intensity. In the Control Group 6 (50%) patients reported no pains and 2 (16,7%) patients noted on decrease of pains up 1 score, in the second group 8 (66,7%) and 1 (8,3%) correspondingly (p>0,05).

Before the treatment there were complaints in both groups claiming sleep disorders or difficulties in getting asleep or interruptions during sleep. In this connection to the phytotherapeutic complex was added the preparation trioson with a sedative effect in the form of tea or in capsules. All patients of the second group reported normalization of sleeping pattern during three months. At palpatic examination 10 (83,3%) patients of the first group and 11 (91,7%) of the second group firmness of mammary glands was observed. After the treatment the positive changes were noted in 4 (40%) of patients in the control group and 6 (54,5%) in examined (p>0,5). The efficiency of treatment based on subjective evaluation in the first group was 66,7% and 75% in the second correspondingly (p>0,05).

Statements: The complex elaborated by us on the basis of BAA of plant origin was aimed at the main causes of dyshormonal disorders (light, sedative, soporific, antidepressant, antibruise, antixidant, normalization of liver functions, ovaries, thyroid gland, strengthening of the blood vessels, increase of non-specific stability of the body). In the course of our pilot research we made the following statements:

• the applied method of treatment in patients with diffusive forms of fibrous-cystic illness, including mastodinon, aevit, clamin showed relatively high efficiency - 66,6%.
• more efficiency (75%) was associated with improvement of the general health, decrease or stop of pain syndrome, normalization of sleep was evidenced by combination of mastodinon I conjunction with our BAA complex.
• the present complex may be recommended to increase efficiency of complex therapies of mammary glands diseases.